SCHEMBL16601596

SCHEMBL16601596

CCN1C(=O)COc2cc(C)ccc21

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.55
HTT P42858 1/20 0.55
PLK1 P53350 1/20 0.51
RORC P51449 2/20 0.48
CYP3A4 P08684 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP1A2 P05177 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
TERT O14746 1/20 0.44
POLB P06746 2/20 0.44
SLC5A1 P13866 1/20 0.43
SLC5A2 P31639 1/20 0.43
TP53 P04637 1/20 0.43
ALDH1A1 P00352 1/20 0.43
BRD4 O60885 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16601580 0.88 HTT (0.52) TSHRHTTPLK1CYP3A4CYP2D6
SCHEMBL5986135 0.88 TSHR (0.70) TSHRHTTPLK1CYP3A4CYP2D6
SCHEMBL20116324 0.84 SLC5A1 (0.52) TSHRHTTPLK1RORCCYP3A4
SCHEMBL30336383 0.84 SLC5A1 (0.52) TSHRHTTPLK1RORCCYP3A4
SCHEMBL10196932 0.84 TSHR (0.55) TSHRHTTPLK1CYP3A4CYP2D6
SCHEMBL13367640 0.84 TSHR (0.51) TSHRHTTPLK1CYP3A4CYP2D6
SCHEMBL13962147 0.83 RORC (0.45) TSHRHTTPLK1RORCPOLB
SCHEMBL9275467 0.83 CHRM5 (0.57) TSHRHTTRORCCYP3A4CYP2D6
SCHEMBL8127407 0.83 ATAD2 (0.56) TSHRHTTPLK1RORCKMT2A
SCHEMBL15786430 0.82 TSHR (0.50) TSHRHTTPLK1CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019209948-A9 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS, INC. (US) 2020-01-02 WO disclosed
WO-2019018795-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS (US) 2019-01-24 WO disclosed
WO-2018081167-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS (US) 2018-05-03 WO disclosed
US-8993585-B2 Cyclic amine substituted pyrimidinediamines as PKC inhibitors RIGEL PHARMACEUTICALS, INC. (US) 2015-03-31 US disclosed